KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Apr 01, 2024 Buy 263 960 Bashan Dror Common Stock
Oct 19, 2023 Buy 16 129 Bashan Dror Common Stock
Oct 19, 2023 Buy 48 387 Bashan Dror Common Stock
Sep 29, 2023 Buy 61 676 Boudes Pol F Stock Options (Right to Buy)
Sep 29, 2023 Buy 61 676 Melincoff Gwen A Stock Options (Right to Buy)
Sep 29, 2023 Buy 61 676 Bar-shalev Amos Stock Options (Right to Buy)
Sep 29, 2023 Buy 61 676 Ben Zvi Shmuel Stock Option (Right to Buy)
Sep 29, 2023 Buy 61 676 Schwartz Aharon Stock Option (Right to Buy)
Sep 14, 2023 Buy 85 715 Forster Eliot Stock Options (Right to Buy)
Sep 14, 2023 Buy 0 Forster Eliot
Aug 15, 2023 Buy 800 000 Bashan Dror Common Stock
Aug 15, 2023 Buy 201 903 Rubin Eyal Common Stock
Aug 15, 2023 Buy 35 115 Hayon Yael Common Stock
Aug 15, 2023 Buy 35 115 Hayon Yael Stock Options (Right to Buy)
Aug 15, 2023 Buy 187 344 Naos Yaron Common Stock
Jan 03, 2023 Buy 110 000 Schwartz Aharon Common Stock
Sep 07, 2022 Buy 10 000 Ben Zvi Shmuel Stock Options (Right to Buy)
Sep 07, 2022 Buy 340 000 Naos Yaron Stock Options (Right to Buy)
Sep 07, 2022 Buy 250 000 Hayon Yael Stock Options (Right to Buy)
Sep 07, 2022 Buy 350 000 Rubin Eyal Stock Options (Right to Buy)
Sep 07, 2022 Buy 350 000 Rubin Eyal Stock Options (Right to Buy)
Sep 07, 2022 Buy 750 000 Bashan Dror Stock Options (Right to Buy)
Sep 07, 2022 Buy 50 000 Schwartz Aharon Stock Options (Right to Buy)
Sep 07, 2022 Buy 100 000 Bronfeld Zeev Stock Options (Right to Buy)
Sep 07, 2022 Buy 100 000 Bronfeld Zeev Stock Options (Right to Buy)
Sep 07, 2022 Buy 50 000 Bar-shalev Amos Stock Options (Right to Buy)
Sep 07, 2022 Buy 50 000 Melincoff Gwen A Stock Options (Right to Buy)
Sep 07, 2022 Buy 50 000 Melincoff Gwen A Stock Options (Right to Buy)
Sep 07, 2022 Buy 50 000 Boudes Pol F Stock Options (Right to Buy)
Jun 30, 2022 Buy 40 000 Ben Zvi Shmuel Stock Options (Right to Buy)
Jun 30, 2022 Buy 0 Ben Zvi Shmuel
Apr 11, 2022 Buy 68 000 Bashan Dror Common Stock
Feb 25, 2022 Buy 121 951 Rubin Eyal Common Stock
Feb 25, 2022 Buy 637 531 Bashan Dror Common Stock
Jun 03, 2021 Sell 857 506 Dexcel Pharma Technologies Ltd. Common Stock
Jun 02, 2021 Sell 61 211 Dexcel Pharma Technologies Ltd. Common Stock
Feb 12, 2021 Buy 0 Dexcel Pharma Technologies Ltd. Common Stock
Aug 11, 2020 Buy 246 146 Rubin Eyal Common Stock
Aug 11, 2020 Buy 447 927 Bashan Dror Common Stock
Aug 11, 2020 Buy 246 146 Rubin Eyal Common Stock
Aug 11, 2020 Buy 447 927 Bashan Dror Common Stock
Aug 11, 2020 Buy 122 656 Naos Yaron Stock Options (Right to Buy)
Jul 05, 2020 Buy 129 771 Hayon Yael Stock Options (Right to Buy)
Jul 05, 2020 Buy 0 Hayon Yael
Jun 07, 2020 Buy 196 995 Almon Einat Brill Stock Options (Right to Buy)
Apr 07, 2020 Buy 64 000 Schwartz Aharon Common Stock
Mar 11, 2020 Buy 2 816 901 Dexcel Pharma Technologies Ltd. Common Stock Purchase Warrants
Feb 03, 2020 Buy 240 000 Bronfeld Zeev Stock Options (Right to Buy)
Jan 20, 2020 Buy 40 000 Granot David Stock Options (Right to Buy)
Jan 20, 2020 Buy 40 000 Bar-shalev Amos Stock Options (Right to Buy)
Jan 20, 2020 Buy 40 000 Schwartz Aharon Stock Options (Right to Buy)
Jan 20, 2020 Buy 40 000 Boudes Pol F Stock Options (Right to Buy)
Jan 20, 2020 Buy 40 000 Melincoff Gwen A Stock Options (Right to Buy)
Jan 01, 2020 Buy 0 Melincoff Gwen A
Jan 01, 2020 Buy 0 Boudes Pol F Common Stock
Sep 22, 2019 Buy 800 000 Rubin Eyal Stock Options (Right to Buy)
Sep 22, 2019 Buy 0 Rubin Eyal
Jun 30, 2019 Buy 1 600 000 Bashan Dror Stock Options (Right to Buy)
Jun 30, 2019 Buy 0 Bashan Dror
Sep 13, 2018 Buy 700 000 Maimon Yossi Stock Options (Right to Buy)
Sep 13, 2018 Buy 700 000 Almon Einat Brill Stock Options (Right to Buy)
Sep 13, 2018 Buy 600 000 Naos Yaron Stock Options (Right to Buy)
Sep 13, 2018 Buy 1 300 000 Manor Moshe Stock Options (Right to Buy)
Sep 13, 2018 Buy 700 000 Shaaltiel Yoseph Stock Options (Right to Buy)
Aug 09, 2018 Buy 0 Granot David
May 29, 2018 Buy 0 Naos Yaron Common Stock
May 29, 2018 Buy 0 Naos Yaron Common Stock
May 29, 2018 Buy 115 000 Naos Yaron Stock Options (Right to Buy)
May 29, 2018 Buy 50 000 Naos Yaron Stock Options (Right to Buy)
May 29, 2018 Buy 50 000 Naos Yaron Stock Options (Right to Buy)
May 16, 2017 Buy 50 000 Manor Moshe Common Stock
Dec 02, 2016 Sell 2 500 000 Camber Capital Management Llc Common Stock
Sep 15, 2016 Buy 122 162 Shaaltiel Yoseph Common Stock
Sep 15, 2016 Sell 122 162 Shaaltiel Yoseph Stock Options (Right to Buy)
Dec 14, 2015 Buy 10 000 Maimon Yossi Common Stock
Oct 19, 2015 Buy 423 Camber Capital Management Llc Common Stock
Oct 19, 2015 Buy 4 000 000 Camber Capital Management Llc Common Stock
Oct 15, 2015 Buy 0 Camber Capital Management Llc Common Stock
Oct 15, 2015 Buy 0 Camber Capital Management Llc Convertible Note Contracts
Mar 23, 2015 Buy 250 000 Maimon Yossi Stock Options (Right to Buy)
Mar 23, 2015 Buy 275 000 Shaaltiel Yoseph Stock Options (Right to Buy)
Mar 23, 2015 Buy 125 000 Palash Tzvi Stock Options (Right to Buy)
Mar 23, 2015 Buy 250 000 Almon Einat Brill Stock Options (Right to Buy)
Nov 10, 2014 Buy 0 Schwartz Aharon
Nov 01, 2014 Buy 0 Manor Moshe
Oct 02, 2014 Buy 324 372 Bronfeld Zeev Common Stock
Oct 02, 2014 Sell 1 509 948 Bronfeld Zeev Common Stock
Sep 29, 2014 Buy 900 000 Manor Moshe Stock Options (Right to Buy)
Sep 16, 2014 Buy 1 838 109 Bronfeld Zeev Common Stock
Sep 16, 2014 Sell 8 556 371 Bronfeld Zeev Common Stock
Sep 16, 2014 Sell 8 556 371 Bio-cell Ltd Common Stock
Aug 13, 2014 Sell 4 400 000 Bronfeld Zeev Common Stock
Aug 13, 2014 Sell 4 400 000 Bio-cell Ltd Common Stock
Jul 24, 2014 Buy 150 000 Yanai Shlomo Stock Options (Right to Buy)
Jul 24, 2014 Buy 0 Yanai Shlomo
Aug 15, 2013 Sell 2 330 Akirov Alfred Common Stock
Aug 14, 2013 Sell 100 000 Akirov Alfred Common Stock
Aug 14, 2013 Sell 5 000 Akirov Alfred Common Stock
Aug 14, 2013 Sell 5 000 Akirov Alfred Common Stock
Mar 12, 2013 Sell 10 000 Akirov Alfred Common Stock
INSIDER POWER
96.393
Last 100 transactions
Buy: 25 528 065 | Sell: 31 085 899 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 96.393.

In total, the insiders bought 25 528 065 and sold 31 085 899 PLX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Protalix BioTherapeutics Inc

Protalix BioTherapeutics Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candi... PLX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT